Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat nNOS (neuronal) ELISA Kit (AC2666)
Cat.#: ASET-1255
Specifications
Description Rat nNOS (neuronal) ELISA Kit allows for the in vitro quantitative determination of rat nNOS (neuronal) concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.094 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.156-10 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1440 Mouse Axin 2 ELISA Kit (AC2851) Quantitative inquiry ASET-2069 Mouse Neurotensin ELISA Kit (AC3480) Quantitative inquiry ASET-1811 Human Substance P ELISA Kit (AC3222) Quantitative inquiry ASET-2452 Rat Orexin A ELISA Kit (AC3863) Quantitative inquiry ASET-1690 Human Aspartate beta Hydroxylase ELISA Kit (AC3101) Quantitative inquiry ASET-1597 Human Laminin ELISA Kit (AC3008) Quantitative inquiry ASET-1869 Human Nogo ELISA Kit (AC3280) Quantitative inquiry ASET-2007 Rat ATP1A3 ELISA Kit (AC3418) Quantitative inquiry ASET-2517 Mouse GAPDH ELISA Kit (AC3928) Quantitative inquiry ASET-1249 Mouse SEMA3B ELISA Kit (AC2660) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket